Get an alert when TORRENT PHARMA (UK) LTD files next

Leroy will email you the moment a new filing lands at Companies House — one short note per filing, nothing else.

Free · confirmation link first · unsubscribe in one click

Next accounts due

2026-12-31 (in 7mo)

Last filed for 2025-03-31

Confirmation statement due

2027-03-02 (in 10mo)

Last made up 2026-02-16

Watchouts

None on the register

Cash

£1M

-21.3% vs 2024

Net assets

-£5M

+2.7% vs 2024

Employees

26

0% vs 2024

Profit before tax

£132K

-94.1% vs 2024

Accounts

2-year trend · latest reflected 2025-03-31

Metric Trend 2024-03-312025-03-31
Turnover £22,989,226£16,809,574
Operating profit £3,313,122£910,892
Profit before tax £2,228,801£131,804
Net profit £2,318,932£143,795
Cash £1,495,421£1,176,598
Total assets less current liabilities £4,185,702£3,727,784
Net assets -£5,243,300-£5,099,505
Equity -£5,243,300-£5,099,505
Average employees 2626
Wages £1,306,107£1,451,743

Values shown as filed in the company's annual accounts. indicates the figure wasn't present under that line item in that period. About these numbers

Ratios

Computed from the line items above — sparklines read oldest → newest

Ratio Trend 2024-03-312025-03-31
Operating margin 14.4%5.4%
Net margin 10.1%0.9%
Return on capital employed 79.2%24.4%
Gearing (liabilities / total assets) 142.9%135.0%
Current ratio 1.19x1.11x
Interest cover 3.06x1.17x

Margins divide P&L lines by turnover. Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Sector-distribution context coming next.

Audit & accounting basis

Accounting basis
IFRS
Reporting scope
Standalone (parent only)
Auditor
KNAV Limited
Audit opinion
Unqualified (clean)
Going concern
Affirmed

“The financial statements have been prepared on the assumption that the Company will continue as a going concern. The directors have considered the Company's ability to meet its day-to-day working capital requirements, taking into account its ongoing commercial business contracts, access to financing from fellow group undertakings, and, if required, the continued financial support of its parent company, Torrent Pharmaceuticals Limited. Based on these considerations, the directors are confident that the Company will have sufficient resources to meet its liabilities as they fall due for a period of at least 12 months from the date of approval of the financial statements. Accordingly, the financial statements have been prepared on a going concern basis.”

Group structure

  1. TORRENT PHARMA (UK) LTD · parent
    1. Heumann Pharma Gmbh & Co Generica KG · Germany
    2. Torrent Pharma Inc · USA

Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers

People

3 active · 7 resigned

Name Role Appointed Born Nationality
AGRAWAL, Amul Kamal Kumar Director 2013-10-18 Dec 1977 German
BHATTACHARYA, Abhijit Director 2021-10-04 Mar 1968 British
KAPASHI, Naimi Ashwinbhai Director 2021-10-04 Jul 1982 Indian
Show 7 resigned officers
Name Role Appointed Resigned
DURBIDGE, Jamie Lee Director 2018-07-27 2020-09-30
GUPTA, Sanjay Director 2013-10-18 2021-12-14
HARIHARA, Balkrishna Director 2010-05-11 2013-09-01
MENON, Sudhir Director 2013-10-18 2021-12-14
SHAH, Jinesh Director 2010-05-11 2013-10-18
SOLANKI, Kaushal Singh Director 2018-08-23 2021-12-14
SYLVESTER-WILLIAMS, Innes Director 2010-05-11 2018-09-24

Ownership

Persons with significant control

No persons with significant control on record.

Filing timeline

Last 20 of 59 total filings

Date Type Category Description
2026-03-06 CS01 confirmation-statement Confirmation statement with no updates PDF
2025-07-23 AA accounts Accounts with accounts type full
2025-03-20 CS01 confirmation-statement Confirmation statement with no updates PDF
2024-08-09 AA accounts Accounts with accounts type full
2024-03-21 CS01 confirmation-statement Confirmation statement with no updates PDF
2023-09-26 AA accounts Accounts with accounts type full
2023-02-16 CS01 confirmation-statement Confirmation statement with no updates PDF
2023-02-16 CH01 officers Change person director company with change date PDF
2022-06-24 AA accounts Accounts with accounts type full
2022-03-16 CH01 officers Change person director company with change date PDF
2022-02-16 CS01 confirmation-statement Confirmation statement with no updates PDF
2022-01-10 TM01 officers Termination director company with name termination date PDF
2022-01-10 TM01 officers Termination director company with name termination date PDF
2022-01-10 TM01 officers Termination director company with name termination date PDF
2021-12-13 AP01 officers Appoint person director company with name date PDF
2021-12-13 CH01 officers Change person director company with change date PDF
2021-12-09 AP01 officers Appoint person director company with name date PDF
2021-09-15 AA accounts Accounts with accounts type full
2021-05-21 CS01 confirmation-statement Confirmation statement with no updates PDF
2020-10-02 TM01 officers Termination director company with name termination date PDF

Public-record activity

Raw counts from Companies House — last 12–24 months

Filings
2

last 12 months

Capital events
0

last 24 months

Officers appointed
0

last 12 months

Officers resigned
0

last 12 months

Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.

Year-on-year

FY2024 → FY2025 · period ending 2025-03-31 vs 2024-03-31

Each % is (latest − prior) ÷ |prior| for the line item as filed. The comparison is only shown when the latest and prior accounts cover broadly equal-length periods — short or long stubs (typical around incorporation or a year-end change) are suppressed rather than misrepresented. Lines a company doesn't report are omitted. About these numbers

Official Companies House page